Cigna Files 8-K on Financial Condition & Operations
Ticker: CI · Form: 8-K · Filed: Feb 2, 2024 · CIK: 1739940
| Field | Detail |
|---|---|
| Company | Cigna Group (CI) |
| Form Type | 8-K |
| Filed Date | Feb 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: financial-condition, results-of-operations, 8-K
TL;DR
**Cigna just dropped an 8-K on its financials, time to check the numbers!**
AI Summary
The Cigna Group filed an 8-K on February 2, 2024, to report on its results of operations and financial condition. This filing, under SEC File Number 001-38769, indicates that Cigna is providing an update on its financial performance, which is crucial for investors to understand the company's current health and future prospects. For shareholders, this matters because it offers transparency into the company's earnings and financial stability, directly influencing stock valuation and investment decisions.
Why It Matters
This filing provides investors with the latest financial results, which are essential for evaluating Cigna's performance and making informed investment decisions.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any immediate new risks but rather providing transparency.
Analyst Insight
A smart investor would review the detailed financial statements and results of operations once they become available to assess Cigna's performance and adjust their investment thesis accordingly.
Key Players & Entities
- Cigna Group (company) — the registrant filing the 8-K
- February 2, 2024 (date) — date of earliest event reported and filing date
- 001-38769 (dollar_amount) — Commission File Number
- 82-4991898 (dollar_amount) — IRS Employer Identification No.
- 900 Cottage Grove Road Bloomfield, Connecticut 06002 (company) — address of principal executive offices
- 860-226-6000 (dollar_amount) — registrant's telephone number
- CI (company) — trading symbol for Common Stock
- New York Stock Exchange, Inc. (company) — exchange where Common Stock is registered
FAQ
What is the purpose of this 8-K filing by The Cigna Group?
The Cigna Group filed this 8-K to report on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits, as indicated by the 'ITEM INFORMATION' sections.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 2, 2024, which is also the date of the report.
What is The Cigna Group's Commission File Number and IRS Employer Identification Number?
The Cigna Group's Commission File Number is 001-38769, and its IRS Employer Identification Number is 82-4991898.
Where are The Cigna Group's principal executive offices located?
The Cigna Group's principal executive offices are located at 900 Cottage Grove Road, Bloomfield, Connecticut 06002.
What is the trading symbol and the exchange where The Cigna Group's Common Stock is registered?
The trading symbol for The Cigna Group's Common Stock is CI, and it is registered on the New York Stock Exchange, Inc.
Filing Stats: 509 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-02-02 06:15:28
Key Financial Figures
- $0.01 — ch registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc. I
Filing Documents
- cigna8k.htm (8-K) — 25KB
- ex99-1.htm (EX-99.1) — 269KB
- image_001.jpg (GRAPHIC) — 4KB
- 0000950159-24-000033.txt ( ) — 493KB
- ci-20240202.xsd (EX-101.SCH) — 3KB
- ci-20240202_lab.xml (EX-101.LAB) — 33KB
- ci-20240202_pre.xml (EX-101.PRE) — 22KB
- cigna8k_htm.xml (XML) — 3KB
02
Item 2.02 Results of Operations and Financial Condition. On February 2, 2024, The Cigna Group issued a press release announcing results for the three months and year ended December 31, 2023. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date of this Current Report on Form 8-K, except as shall be expressly set forth by specific reference in such a filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated February 2, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CIGNA GROUP Date: February 2, 2024 By: /s/ Brian C. Evanko Brian C. Evanko Executive Vice President and Chief Financial Officer and President and Chief Executive Officer, Cigna Healthcare